Litcius/Paper detail

A tumor-targeted delivery of oral isoliquiritigenin through encapsulated zein phosphatidylcholine hybrid nanoparticles prevents triple-negative breast cancer

Yan Wang, Chen Zhang, Meng Xiao, Kumar Ganesan, Fei Gao, Qingqing Liu, Zhen Ye, Yue Sui, Feng Zhang, Kunhua Wei, Yaobin Wu, Jianmin Wu, Bing Du, Cong Xu, Yan Li, Peng Li, Jinming Zhang, Jianping Chen

2022Journal of Drug Delivery Science and Technology24 citationsDOI

Topics & Concepts

IsoliquiritigeninBiodistributionTriple-negative breast cancerIn vivoPharmacokineticsPharmacologyChemistryCmaxDrug deliveryBreast cancerCancer researchMedicineCancerMaterials scienceIn vitroNanotechnologyInternal medicineBiochemistryBiologyBiotechnologyPharmacological Effects of Natural CompoundsGinseng Biological Effects and ApplicationsToxin Mechanisms and Immunotoxins
A tumor-targeted delivery of oral isoliquiritigenin through encapsulated zein phosphatidylcholine hybrid nanoparticles prevents triple-negative breast cancer | Litcius